Efficacy of Esaxerenone Plus a Renin–Angiotensin System Inhibitor or Calcium Channel Blocker for Nocturnal Hypertension: A Post Hoc Analysis
Esaxerenone when used in combination with a CCB or RASi, but especially when used in combination with a RASi, may be a useful treatment option for patients with uncontrolled hypertension to control nocturnal BP.
Authors
- Yasuyuki Okuda (ORCID: https://orcid.org/0000-0001-7087-0384)
- Kazuomi Kario (ORCID: https://orcid.org/0000-0002-8251-4480)
- Hiromi Rakugi (ORCID: https://orcid.org/0000-0001-6508-4338)
- Sadayoshi Ito (ORCID: https://orcid.org/0000-0002-5092-3626)
- Hiroshi Itoh (ORCID: https://orcid.org/0000-0003-2514-4919)
- Satoru Yamakawa
Institutions
- Jichi Medical University (JP)
- Daiichi Sankyo (Germany) (DE)
- Tohoku University (JP)
- Keio University (JP)
- Daiichi-Sankyo (Japan) (JP)
- Osaka Rosai Hospital (JP)
- Daiichi Sankyo (India) (IN)
- Japan Organization of Occupational Health and Safety (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- American Journal of Hypertension
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1093/ajh/hpaf048
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00